Charming Medical Limited Notified of Anticipated Delisting from The Nasdaq Stock Market
Key Highlights
- ➤Charming Medical (MCTA) faces Nasdaq delisting on November 9, 2026, absent an appeal
- ➤MCTA securities remain halted and unavailable to trade pending appeal resolution
- ➤Nasdaq halted MCTA shares on November 26, 2025, after an SEC trading suspension
- ➤MCTA may become eligible for over-the-counter trading following Nasdaq removal
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market (Nasdaq: NDAQ) announced today that it has notified Charming Medical Limited (Nasdaq: MCTA) that its securities will be delisted from the Nasdaq Stock Market LLC on November 9, 2026, unless the company appeals to a Listing Qualifications Hearings Panel. The securities will remain halted, and unavailable to trade, until any appeal is resolved. Following removal from Nasdaq the securities may be eligible for trading in the over-the-counter market.
Following a temporary trading suspension in the Company’s securities by the U.S. Securities and Exchange Commission Nasdaq halted trading in the Company’s ordinary shares on November 26, 2025. Nasdaq has now determined that it is appropriate to use its authority under IM-5101-4 to delist the Company’s securities from Nasdaq.
Get started
Create a free account to read the full story.